JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
3201
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $2.1M | ﹤0.01% |
+68,600
| New | +$1.9M |
|
|
SVM
3202
Silvercorp Metals
SVM
$2.61B
| $2.1M | ﹤0.01% |
370,511
-831,468
| -69% | -$3.87M |
|
3203
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.12B
| $2.1M | ﹤0.01% |
70,000
| – | – |
|
3204
CALL
Ally Financial
ALLY
$13.6B
| $2.09M | ﹤0.01% |
+68,400
| New | +$2.14M |
|
3205
Oppenheimer Holdings
OPY
$1.23B
| $2.09M | ﹤0.01% |
76,097
+22,525
| +42% | +$628K |
|
|
KDNY
3206
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.09M | ﹤0.01% |
353,860
+61,710
| +21% | +$335K |
|
|
ZUO
3207
DELISTED
Zuora, Inc.
ZUO
| $2.08M | ﹤0.01% |
145,302
-48,450
| -25% | -$710K |
|
3208
MGE Energy Inc
MGEE
$3.06B
| $2.08M | ﹤0.01% |
26,382
-35,229
| -57% | -$2.71M |
|
|
INFO
3209
CALL
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $2.08M | ﹤0.01% |
+27,600
| New | +$1.96M |
|
3210
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
| $2.08M | ﹤0.01% |
66,312
+749
| +1% | +$22.8K |
|
3211
Marcus Corp
MCS
$929M
| $2.07M | ﹤0.01% |
65,273
-71,651
| -52% | -$2.42M |
|
|
BSCM
3212
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $2.07M | ﹤0.01% |
96,421
+77,291
| +404% | +$1.66M |
|
3213
NeoGenomics
NEO
$2.11B
| $2.07M | ﹤0.01% |
70,811
+27,846
| +65% | +$663K |
|
3214
Galicia Financial Group
GGAL
$7.23B
| $2.06M | ﹤0.01% |
127,140
-181,426
| -59% | -$2.4M |
|
3215
OneSpaWorld
OSW
$2.73B
| $2.06M | ﹤0.01% |
122,388
+107,498
| +722% | +$1.69M |
|
3216
PUT
Xerox
XRX
$412M
| $2.06M | ﹤0.01% |
+55,900
| New | +$1.95M |
|
3217
Hamilton Beach Brands
HBB
$447M
| $2.06M | ﹤0.01% |
107,792
+16,406
| +18% | +$301K |
|
|
AVNS
3218
DELISTED
Avanos Medical
AVNS
| $2.05M | ﹤0.01% |
60,906
-200,753
| -77% | -$7.27M |
|
3219
PUT
Malibu Boats
MBUU
$573M
| $2.05M | ﹤0.01% |
+50,000
| New | +$1.81M |
|
3220
Addus HomeCare
ADUS
$2.2B
| $2.04M | ﹤0.01% |
21,023
-41,511
| -66% | -$3.65M |
|
|
ECHO
3221
EchoStar
ECHO
$26.6B
| $2.04M | ﹤0.01% |
47,187
+3,875
| +9% | +$156K |
|
3222
Standex International
SXI
$3.97B
| $2.04M | ﹤0.01% |
25,716
+1,719
| +7% | +$131K |
|
3223
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.12B
| $2.03M | ﹤0.01% |
68,142
+3,011
| +5% | +$88.4K |
|
|
XLNX
3224
PUT
DELISTED
Xilinx Inc
XLNX
| $2.03M | ﹤0.01% |
20,800
| – | – |
|
|
TTM
3225
DELISTED
Tata Motors Limited
TTM
| $2.03M | ﹤0.01% |
157,132
+157,057
| +209,409% | +$1.73M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.